Exact Mass: 484.23938419999996
Exact Mass Matches: 484.23938419999996
Found 302 metabolites which its exact mass value is equals to given mass value 484.23938419999996
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Kanamycin
C18H36N4O11 (484.23804659999996)
Kanamycin is only found in individuals that have used or taken this drug. It is an antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. [PubChem]Aminoglycosides like kanamycin "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. Specifically Kanamycin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Kanamycin C
C18H36N4O11 (484.23804659999996)
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Nebramycin III
C18H36N4O11 (484.23804659999996)
Plantaricin BN
Plantaricin BN is produced by Lactobacillus plantarum BN. Production by Lactobacillus plantarum BN
BioMed 101
D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
[3R-[3alpha,5beta,5aalpha,6alpha(E),7alpha,9alpha,9aalpha]]-5,7-bis(Acetyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-6-yl ester 3-phenyl-2-propenoic acid
Angeloyl-(+)-gomisin K3
(23R)-5.beta.,6.beta.:12,22-Diepoxy-12.beta.,17.beta.-dihydroxy-1-oxoergosta-2,24-dien-23,26-olide
Segetalin B
Segetalin B, a cyclopentapeptide from Vaccaria segetalis, possesses estrogen-like activity[1][2]. Segetalin B, a cyclopentapeptide from Vaccaria segetalis, possesses estrogen-like activity[1][2]. Segetalin B, a cyclopentapeptide from Vaccaria segetalis, possesses estrogen-like activity[1][2].
20-Hydroxytubocapsanolide A
A withanolide that is the 20-hydroxy derivative of tubocapsanolide A. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.
(5alpha,6alpha,7alpha,17alphaOH,22S)-6,7-Epoxy-5,17-dihydroxy-1,12-dioxowitha-2,24-dienolide
12alpha-acetoxy-7alpha,21-dihydroxy-24,25,26,27-tetranor-3-oxoapotirucalla-1,14,20(22)-trien-23,21-olide|turraparvin B
(20R,22R)-5beta,6beta:12alpha,21-diepoxy-12beta,17beta-dihydroxy-1-oxowitha-2,24-dien-26,22-olide|jaborosalactone 38
1beta,2beta-diacetoxy-9alpha-cinnamoyloxy-beta-dihydroagarofuran
(20R,22R,23S)-5beta,6beta-epoxy-12beta,17beta,22-trihydroxy-1-oxo-12,23-cycloergosta-2,24-dien-26,23-olide|jaborosalactone 11
(20S,22S)-5beta,6beta:12alpha,22-diepoxy-12beta,17beta-dihydroxy-1-oxo-witha-2,24-dien-26,22-olide|jaborosalactone 26|jaborosalactone 46
(17S,18R,20R,22R)-5beta,6beta:18,20-diepoxy-18-hydroxy-1-oxowitha-2,5,24-trienolide
(20S,22S)-12alpha,22-epoxy-6beta,12beta,17beta-trihydroxy-1-oxo-witha-2,4,24-trien-26,22-olide|jaborosalactone 30
(20S,23R)-12beta,26-epoxy-5alpha,6beta,17beta-trihydroxy-26-oxo-12alpha,23-cycloergosta-2,24-dien-1,22-dione|jaborosalactone 31
5beta,6beta-epoxy-4beta,16beta,27-trihydroxy-1-oxo-witha-2,17(20),24-trienolide
5-[(2E,6S)-6,7-dihydroxy-3,7-dimethyl-2-octen-1-yl]-2-(beta-D-glucopyranosyloxy)methyl benzoate
withahisolide G|[(20S,22R,24R,25S)-5alpha,24,25,26-tetrahydroxy-17(13?18)-abeo-ergost-2,13,15,17-tetraen-1-one]
(6aR,9S,9aS)-3-[(1R,2R,4S)-4-hydroxy-2-methyl-6-oxocyclohexyl]-6a-methyl-9-[(2S)-2-methyloctanoyl]-9,9adihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione|cohaerin G
3beta,14S,15-trihydroxy-6alpha,18-diacetoxy-4alpha,17-epoxyclerodan-11,16-lactone
(17R,20S,22R)-5beta,6beta-epoxy-4beta,16alpha-dihydroxy-1,18-dioxowitha-2,24-dienolide
12alpha-acetoxy-7alpha,23-dihydroxy-24,25,26,27-tetranor-3-oxoapotirucalla-1,14,20(22)-trien-21,23-olide|turraparvin A
6beta-benzoyl-5alpha,7beta-dihydroxy-12,16-epoxy-12alpha-methoxycassa-13(15)-en-16-one|neocaesalpin F
kanamycin
C18H36N4O11 (484.23804659999996)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Aminoglycosides KEIO_ID K002; [MS2] KO009014 KEIO_ID K002
9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone
Kanamycin a
C18H36N4O11 (484.23804659999996)
http://casmi-contest.org/challenges-cat1-2.shtml; CASMI2012 LC Challenge 1
9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based: Match]
9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based on: CCMSLIB00000845034]
9-(1H-indol-3-ylmethyl)-6,12-dimethyl-3-propan-2-yl-1,4,7,10,13-pentazacyclopentadecane-2,5,8,11,14-pentone [IIN-based on: CCMSLIB00000845033]
Ala Phe Phe Thr
Ala Phe Thr Phe
Ala Thr Phe Phe
Cys His Ile Ile
C21H36N6O5S (484.24677660000003)
Cys His Ile Leu
C21H36N6O5S (484.24677660000003)
Cys His Leu Ile
C21H36N6O5S (484.24677660000003)
Cys His Leu Leu
C21H36N6O5S (484.24677660000003)
Cys Ile His Ile
C21H36N6O5S (484.24677660000003)
Cys Ile His Leu
C21H36N6O5S (484.24677660000003)
Cys Ile Ile His
C21H36N6O5S (484.24677660000003)
Cys Ile Leu His
C21H36N6O5S (484.24677660000003)
Cys Leu His Ile
C21H36N6O5S (484.24677660000003)
Cys Leu His Leu
C21H36N6O5S (484.24677660000003)
Cys Leu Ile His
C21H36N6O5S (484.24677660000003)
Cys Leu Leu His
C21H36N6O5S (484.24677660000003)
Phe Ala Phe Thr
Phe Ala Thr Phe
Phe Phe Ala Thr
Phe Phe Thr Ala
Phe Gly Val Tyr
Phe Gly Tyr Val
Phe Thr Ala Phe
Phe Thr Phe Ala
Phe Val Gly Tyr
Phe Val Tyr Gly
Phe Tyr Gly Val
Phe Tyr Val Gly
Gly Phe Val Tyr
Gly Phe Tyr Val
Gly Val Phe Tyr
Gly Val Tyr Phe
Gly Tyr Phe Val
Gly Tyr Val Phe
His Cys Ile Ile
C21H36N6O5S (484.24677660000003)
His Cys Ile Leu
C21H36N6O5S (484.24677660000003)
His Cys Leu Ile
C21H36N6O5S (484.24677660000003)
His Cys Leu Leu
C21H36N6O5S (484.24677660000003)
His Ile Cys Ile
C21H36N6O5S (484.24677660000003)
His Ile Cys Leu
C21H36N6O5S (484.24677660000003)
His Ile Ile Cys
C21H36N6O5S (484.24677660000003)
His Ile Leu Cys
C21H36N6O5S (484.24677660000003)
His Lys Asn Ser
C19H32N8O7 (484.23938419999996)
His Lys Ser Asn
C19H32N8O7 (484.23938419999996)
His Leu Cys Ile
C21H36N6O5S (484.24677660000003)
His Leu Cys Leu
C21H36N6O5S (484.24677660000003)
His Leu Ile Cys
C21H36N6O5S (484.24677660000003)
His Leu Leu Cys
C21H36N6O5S (484.24677660000003)
His Met Val Val
C21H36N6O5S (484.24677660000003)
His Asn Lys Ser
C19H32N8O7 (484.23938419999996)
His Asn Ser Lys
C19H32N8O7 (484.23938419999996)
His Ser Lys Asn
C19H32N8O7 (484.23938419999996)
His Ser Asn Lys
C19H32N8O7 (484.23938419999996)
His Val Met Val
C21H36N6O5S (484.24677660000003)
His Val Val Met
C21H36N6O5S (484.24677660000003)
Ile Cys His Ile
C21H36N6O5S (484.24677660000003)
Ile Cys His Leu
C21H36N6O5S (484.24677660000003)
Ile Cys Ile His
C21H36N6O5S (484.24677660000003)
Ile Cys Leu His
C21H36N6O5S (484.24677660000003)
Ile His Cys Ile
C21H36N6O5S (484.24677660000003)
Ile His Cys Leu
C21H36N6O5S (484.24677660000003)
Ile His Ile Cys
C21H36N6O5S (484.24677660000003)
Ile His Leu Cys
C21H36N6O5S (484.24677660000003)
Ile Ile Cys His
C21H36N6O5S (484.24677660000003)
Ile Ile His Cys
C21H36N6O5S (484.24677660000003)
Ile Leu Cys His
C21H36N6O5S (484.24677660000003)
Ile Leu His Cys
C21H36N6O5S (484.24677660000003)
Lys His Asn Ser
C19H32N8O7 (484.23938419999996)
Lys His Ser Asn
C19H32N8O7 (484.23938419999996)
Lys Asn His Ser
C19H32N8O7 (484.23938419999996)
Lys Asn Ser His
C19H32N8O7 (484.23938419999996)
Lys Ser His Asn
C19H32N8O7 (484.23938419999996)
Lys Ser Asn His
C19H32N8O7 (484.23938419999996)
Leu Cys His Ile
C21H36N6O5S (484.24677660000003)
Leu Cys His Leu
C21H36N6O5S (484.24677660000003)
Leu Cys Ile His
C21H36N6O5S (484.24677660000003)
Leu Cys Leu His
C21H36N6O5S (484.24677660000003)
Leu His Cys Ile
C21H36N6O5S (484.24677660000003)
Leu His Cys Leu
C21H36N6O5S (484.24677660000003)
Leu His Ile Cys
C21H36N6O5S (484.24677660000003)
Leu His Leu Cys
C21H36N6O5S (484.24677660000003)
Leu Ile Cys His
C21H36N6O5S (484.24677660000003)
Leu Ile His Cys
C21H36N6O5S (484.24677660000003)
Leu Leu Cys His
C21H36N6O5S (484.24677660000003)
Leu Leu His Cys
C21H36N6O5S (484.24677660000003)
Met His Val Val
C21H36N6O5S (484.24677660000003)
Met Val His Val
C21H36N6O5S (484.24677660000003)
Met Val Val His
C21H36N6O5S (484.24677660000003)
Asn His Lys Ser
C19H32N8O7 (484.23938419999996)
Asn His Ser Lys
C19H32N8O7 (484.23938419999996)
Asn Lys His Ser
C19H32N8O7 (484.23938419999996)
Asn Lys Ser His
C19H32N8O7 (484.23938419999996)
Asn Ser His Lys
C19H32N8O7 (484.23938419999996)
Asn Ser Lys His
C19H32N8O7 (484.23938419999996)
Ser His Lys Asn
C19H32N8O7 (484.23938419999996)
Ser His Asn Lys
C19H32N8O7 (484.23938419999996)
Ser Lys His Asn
C19H32N8O7 (484.23938419999996)
Ser Lys Asn His
C19H32N8O7 (484.23938419999996)
Ser Asn His Lys
C19H32N8O7 (484.23938419999996)
Ser Asn Lys His
C19H32N8O7 (484.23938419999996)
Thr Ala Phe Phe
Thr Phe Ala Phe
Thr Phe Phe Ala
Val Phe Gly Tyr
Val Phe Tyr Gly
Val Gly Phe Tyr
Val Gly Tyr Phe
Val His Met Val
C21H36N6O5S (484.24677660000003)
Val His Val Met
C21H36N6O5S (484.24677660000003)
Val Met His Val
C21H36N6O5S (484.24677660000003)
Val Met Val His
C21H36N6O5S (484.24677660000003)
Val Val His Met
C21H36N6O5S (484.24677660000003)
Val Val Met His
C21H36N6O5S (484.24677660000003)
Val Tyr Phe Gly
Val Tyr Gly Phe
Tyr Phe Gly Val
Tyr Phe Val Gly
Tyr Gly Phe Val
Tyr Gly Val Phe
Tyr Val Phe Gly
Tyr Val Gly Phe
Fentonium
C31H34NO4+ (484.24877040000007)
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
(1S)-4,4,4-trifluoro-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-3-(trifluoromethyl)butane-1,3-diol
C24H34F6O3 (484.24120059999996)
(2S,3R,4R,5S,6S)-2-(Aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2R,3S,4R,5R,6S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol
C18H36N4O11 (484.23804659999996)
23-Hydroxytubocapsanolide A
A withanolide that is the 23-hydroxy derivative of tubocapsanolide A. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-(1,3-benzodioxol-5-yl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(2R)-2-[(4S,5S)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
1-(1,3-benzodioxol-5-yl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
[(1R)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C29H32N4O3 (484.24742819999994)
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
(2R)-2-[(4S,5R)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
1-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-propan-2-ylurea
(4R,7R,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7S,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7S,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
N-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea
(2S)-2-[(4R,5R)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
(2R)-2-[(4R,5S)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
(2R)-2-[(4R,5S)-8-(1-cyclopentenyl)-4-methyl-5-[[methyl-(phenylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C27H36N2O4S (484.23956560000005)
1-(1,3-benzodioxol-5-yl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(4S,7R,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7R,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7R,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4R,7S,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7S,8R)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
(4S,7R,8S)-14-(methanesulfonamido)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
N-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(4S,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
[(1S,2R,4aR,5S,7R,8S,8aR)-8-[(3aR,6aS)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-1,2,3-trihydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-4a-yl]methyl acetate
[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] octanoate
[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] nonanoate
[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] undecanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] dodecanoate
[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tridecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] nonanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] octanoate
[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] tridecanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] decanoate
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] dodecanoate
[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] undecanoate
(2S,3R,4R,5S,6S)-2-(aminomethyl)-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol
C18H36N4O11 (484.23804659999996)
3-[1,4,4-tris(2-carboxyethyl)-2,3-dioxocyclododecyl]propanoic acid
3-deamino-3-hydroxykanamycin B
C18H36N4O11 (484.23804659999996)
A kanamycin that is kanamycin B in which the 3-amino group has been replaced by a hydroxy group.